Moreover, a father and son diagnosed with atypical chronic myeloid leukemia (aCML) were both found to carry SETBP1 mutations, which are present in 24.3% of aCML patients (21). This evidence concerns the gene SETBP1 and atypical chronic myeloid leukemia, BCR-ABL1 negative.